TETRACYCLINE HYDROCHLORIDE

TETRACYCLINE HYDROCHLORIDE was reported 1133 times

TETRACYCLINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BACTERIAL NAIL INFECTION 1 0.1429
1 PYOGENIC STERILE ARTHRITIS PYODERMA GANGRENOSUM AND ACNE SYNDROME 1 0.0833
2 PANCREATIC PHLEGMON 1 0.0714
3 SQUAMOUS CELL CARCINOMA ANTIGEN INCREASED 1 0.0714
4 CARBOHYDRATE TOLERANCE DECREASED 1 0.0455
5 FUNCTIONAL ENDOSCOPIC SINUS SURGERY 1 0.0370
6 RETROPERITONEAL OEDEMA 1 0.0345
7 HOMOCYSTINAEMIA 1 0.0303
8 CAMPYLOBACTER TEST POSITIVE 2 0.0263
9 BONE HYPERPIGMENTATION 2 0.0247
10 GASTROINTESTINAL ANASTOMOTIC STENOSIS 2 0.0211
11 HEPATIC ENZYME 3 0.0201
12 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 2 0.0190
13 NEUROPATHIC ULCER 1 0.0185
14 LOSS OF VISUAL CONTRAST SENSITIVITY 1 0.0159
15 PERIPHERAL VENOUS DISEASE 64 0.0157
16 FINGER DEFORMITY 75 0.0155
17 FACET JOINT SYNDROME 48 0.0147
18 ACQUIRED PORPHYRIA 1 0.0141
19 MUSCLE TENSION DYSPHONIA 1 0.0125
20 SCIATIC NERVE PALSY 1 0.0122
21 PALATE INJURY 1 0.0120
22 TETHERED ORAL TISSUE 1 0.0119
23 HEMIANOPIA HETERONYMOUS 1 0.0116
24 HUMAN CHORIONIC GONADOTROPIN DECREASED 1 0.0090
25 ONYCHOMYCOSIS 39 0.0089
26 SHIGELLA INFECTION 1 0.0088
27 DERMATOPHYTOSIS OF NAIL 1 0.0084
28 RHEUMATIC FEVER 35 0.0078
29 BLEPHAROSPASM 49 0.0078
30 BREAST CANCER STAGE III 50 0.0077
31 ENDOMETRIAL CANCER RECURRENT 1 0.0076
32 ONYCHOMADESIS 32 0.0076
33 FOLLICULITIS 78 0.0074
34 TUBERCULIN TEST POSITIVE 18 0.0071
35 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 16 0.0069
36 C-REACTIVE PROTEIN ABNORMAL 41 0.0064
37 BENIGN INTRACRANIAL HYPERTENSION 8 0.0064
38 BURSITIS 77 0.0063
39 BACK INJURY 69 0.0063
40 VENTRICULAR TACHYARRHYTHMIA 2 0.0063
41 DUODENAL ULCER PERFORATION 45 0.0060
42 TOOTH MALFORMATION 1 0.0058
43 HYPOCHOLESTEROLAEMIA 2 0.0057
44 PRODUCT LABEL CONFUSION 33 0.0057
45 WOUND INFECTION 61 0.0056
46 HELICOBACTER INFECTION 57 0.0055
47 HYPERCHOLESTEROLAEMIA 51 0.0053
48 PERINEAL INFECTION 1 0.0051
49 PECTUS EXCAVATUM 1 0.0049
50 NAIL OPERATION 2 0.0048
51 SALMONELLA BACTERAEMIA 1 0.0048
52 RHEGMATOGENOUS RETINAL DETACHMENT 1 0.0048
53 EMPTY SELLA SYNDROME 1 0.0046
54 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 3 0.0045
55 ANASTOMOTIC ULCER 2 0.0043
56 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 29 0.0040
57 NAIL DISORDER 34 0.0039
58 DEVICE WIRELESS COMMUNICATION ISSUE 1 0.0039
59 NORMAL NEWBORN 21 0.0039
60 SCROTAL ULCER 1 0.0038
61 RHEUMATOID FACTOR POSITIVE 22 0.0038
62 CSF PRESSURE INCREASED 1 0.0038
63 EAR NEOPLASM 1 0.0036
64 PANCREATIC DUCT DILATATION 1 0.0036
65 LIVER FUNCTION TEST INCREASED 78 0.0036
66 OBESITY 57 0.0036
67 CARBUNCLE 1 0.0035
68 HEPATITIS 88 0.0034
69 MUSCLE INJURY 28 0.0034
70 INCREASED DOSE ADMINISTERED 1 0.0032
71 GRIP STRENGTH DECREASED 28 0.0032
72 BOWEL SOUNDS ABNORMAL 1 0.0032
73 TASTE DISORDER 64 0.0032
74 SHORT-BOWEL SYNDROME 2 0.0031
75 PENILE ULCERATION 1 0.0031
76 SYNOVITIS 52 0.0029
77 LORDOSIS 1 0.0028
78 X-RAY ABNORMAL 5 0.0028
79 LIVE BIRTH 23 0.0027
80 BRONCHOPNEUMOPATHY 1 0.0027
81 PEMPHIGUS 34 0.0027
82 ACETABULUM FRACTURE 1 0.0027
83 COELIAC DISEASE 26 0.0026
84 LIP DRY 24 0.0026
85 ALKALOSIS 1 0.0026
86 RED BLOOD CELL TRANSFUSION 1 0.0024
87 REACTION TO COLOURING 1 0.0024
88 CAMPYLOBACTER INFECTION 2 0.0024
89 OTITIS MEDIA CHRONIC 1 0.0024
90 LUPUS VULGARIS 3 0.0024
91 BONE SCAN ABNORMAL 1 0.0024
92 INFUSION SITE REACTION 7 0.0023
93 INCORRECT PRODUCT ADMINISTRATION DURATION 50 0.0023
94 VULVOVAGINAL RASH 1 0.0023
95 ADVERSE REACTION 30 0.0023
96 IRIDOCYCLITIS 7 0.0022
97 SWOLLEN JOINT COUNT INCREASED 7 0.0022
98 BONE INFARCTION 1 0.0022
99 PERICARDITIS 36 0.0021
100 HAND DEFORMITY 28 0.0021
101 ECZEMA ASTEATOTIC 1 0.0021
102 PULMONARY VASCULAR DISORDER 1 0.0021
103 FIBROMYALGIA 50 0.0021
104 DEEP VEIN THROMBOSIS POSTOPERATIVE 4 0.0020
105 RIGHT ATRIAL DILATATION 1 0.0020
106 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 1 0.0020
107 GAIT INABILITY 62 0.0019
108 DRUG EFFECT PROLONGED 1 0.0018
109 SEROSITIS 1 0.0018
110 TONSILLECTOMY 3 0.0018
111 HELICOBACTER TEST POSITIVE 1 0.0018
112 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 1 0.0018
113 IDIOPATHIC INTRACRANIAL HYPERTENSION 4 0.0018
114 TOOTH DISCOLOURATION 5 0.0017
115 BLOOD OESTROGEN INCREASED 1 0.0017
116 ILEAL STENOSIS 3 0.0017
117 JOINT RANGE OF MOTION DECREASED 22 0.0016
118 MONOCYTE COUNT DECREASED 2 0.0016
119 NECK PAIN 91 0.0016
120 LOWER EXTREMITY MASS 1 0.0016
121 CORTISOL INCREASED 1 0.0016
122 HEPATOBILIARY DISEASE 1 0.0016
123 OSTEOARTHRITIS 67 0.0016
124 WOUND 44 0.0016
125 THYROXINE FREE INCREASED 1 0.0016
126 MITRAL VALVE CALCIFICATION 1 0.0016
127 INFLAMMATION 80 0.0015
128 ALLERGIC OEDEMA 1 0.0015
129 KLEBSIELLA TEST POSITIVE 1 0.0015
130 GINGIVAL DISCOMFORT 1 0.0015
131 VULVAL DISORDER 1 0.0015
132 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 3 0.0014
133 IRRITABLE BOWEL SYNDROME 31 0.0014
134 THERAPEUTIC PROCEDURE 2 0.0014
135 OVERLAP SYNDROME 1 0.0014
136 GLOSSODYNIA 32 0.0014
137 TYPE 2 DIABETES MELLITUS 48 0.0014
138 PELVIC FLUID COLLECTION 1 0.0014
139 EPILEPSY 43 0.0014
140 JARISCH-HERXHEIMER REACTION 1 0.0014
141 IMMUNISATION REACTION 1 0.0014
142 PARATHYROID TUMOUR BENIGN 1 0.0013
143 SYSTEMIC LUPUS ERYTHEMATOSUS 47 0.0013
144 DISLOCATION OF VERTEBRA 3 0.0013
145 MOBILITY DECREASED 94 0.0013
146 RETINAL PIGMENTATION 1 0.0013
147 ABDOMINAL ADHESIONS 4 0.0013
148 TINEA PEDIS 2 0.0013
149 EXCESSIVE GRANULATION TISSUE 1 0.0012
150 WHEEZING 73 0.0012
151 VACCINATION COMPLICATION 1 0.0012
152 BRADYARRHYTHMIA 2 0.0012
153 INJURY 85 0.0012
154 CONGENITAL CARDIOVASCULAR ANOMALY 1 0.0012
155 INTENTIONAL PRODUCT USE ISSUE 104 0.0012
156 CRANIOFACIAL FRACTURE 1 0.0012
157 OTORRHOEA 2 0.0011
158 STEROID DEPENDENCE 1 0.0011
159 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 1 0.0011
160 THERAPEUTIC PRODUCT CROSS-REACTIVITY 1 0.0011
161 PRIMARY SEQUESTRUM 1 0.0011
162 CONDUCTION DISORDER 2 0.0011
163 COLOUR BLINDNESS 1 0.0011
164 STOMATITIS 66 0.0011
165 SKIN TEST POSITIVE 1 0.0011
166 BLISTER 60 0.0011
167 MATERNAL EXPOSURE TIMING UNSPECIFIED 4 0.0011
168 CONTRAINDICATED PRODUCT ADMINISTERED 32 0.0011
169 DRUG-INDUCED LIVER INJURY 33 0.0011
170 GASTROOESOPHAGEAL REFLUX DISEASE 84 0.0010
171 VAGINAL DISORDER 1 0.0010
172 ULCER HAEMORRHAGE 7 0.0010
173 BONE SWELLING 1 0.0010
174 MASTOIDITIS 1 0.0010
175 IMMUNE-MEDIATED DERMATITIS 1 0.0010
176 EYE INJURY 3 0.0010
177 IMPAIRED HEALING 32 0.0010
178 EYE CONTUSION 2 0.0009
179 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
180 HYPERTENSIVE NEPHROPATHY 1 0.0009
181 LIVER INJURY 23 0.0009
182 UTERINE PROLAPSE 1 0.0009
183 TOXIC ANTERIOR SEGMENT SYNDROME 1 0.0009
184 ACARODERMATITIS 1 0.0009
185 POST PROCEDURAL SWELLING 1 0.0009
186 PSORIATIC ARTHROPATHY 37 0.0009
187 DRY AGE-RELATED MACULAR DEGENERATION 1 0.0009
188 NIGHT SWEATS 29 0.0009
189 INTRACRANIAL PRESSURE INCREASED 5 0.0009
190 METABOLIC SURGERY 1 0.0009
191 BLOOD CHOLESTEROL INCREASED 41 0.0009
192 BLOODY DISCHARGE 1 0.0009
193 BLADDER OPERATION 1 0.0009
194 RESTRICTIVE PULMONARY DISEASE 1 0.0009
195 C-REACTIVE PROTEIN INCREASED 30 0.0008
196 PHARYNGEAL INFLAMMATION 1 0.0008
197 OTITIS EXTERNA 1 0.0008
198 TOOTH EROSION 1 0.0008
199 RENAL ATROPHY 1 0.0008
200 TACHYARRHYTHMIA 2 0.0008
201 HYPERAESTHESIA TEETH 1 0.0008
202 INFUSION SITE IRRITATION 1 0.0008
203 CONGENITAL ANOMALY 6 0.0008
204 ADJUSTMENT DISORDER 1 0.0008
205 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
206 LIP EXFOLIATION 1 0.0008
207 MUSCULAR WEAKNESS 84 0.0007
208 AGORAPHOBIA 1 0.0007
209 RHONCHI 1 0.0007
210 GLUTEN SENSITIVITY 1 0.0007
211 DRUG INTOLERANCE 68 0.0007
212 LOWER RESPIRATORY TRACT INFECTION 32 0.0007
213 PELVIC VENOUS THROMBOSIS 1 0.0007
214 EXPOSURE DURING PREGNANCY 43 0.0007
215 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
216 PULMONARY VALVE INCOMPETENCE 1 0.0007
217 BILIARY DILATATION 1 0.0007
218 HYPERSENSITIVITY 125 0.0007
219 HYPERTHERMIA MALIGNANT 1 0.0007
220 ATYPICAL PNEUMONIA 2 0.0007
221 LUPUS-LIKE SYNDROME 6 0.0007
222 PNEUMONIA PSEUDOMONAL 1 0.0007
223 HYPERTROPHIC CARDIOMYOPATHY 1 0.0006
224 JOINT SWELLING 78 0.0006
225 VASCULAR RUPTURE 1 0.0006
226 JOINT DESTRUCTION 1 0.0006
227 SLEEP DISORDER 45 0.0006
228 MEGACOLON 1 0.0006
229 RHEUMATOID ARTHRITIS 72 0.0006
230 INTERMITTENT CLAUDICATION 1 0.0006
231 DRY MOUTH 51 0.0006
232 ILL-DEFINED DISORDER 38 0.0006
233 UNDERDOSE 45 0.0006
234 HEPATIC ENZYME INCREASED 41 0.0006
235 GASTRIC DILATATION 1 0.0006
236 TYMPANIC MEMBRANE PERFORATION 1 0.0006
237 BILIARY DYSKINESIA 1 0.0006
238 SKIN WOUND 1 0.0006
239 BLOOD AMYLASE INCREASED 1 0.0006
240 PUSTULAR PSORIASIS 2 0.0006
241 RETINITIS 1 0.0006
242 ARTHROPATHY 32 0.0006
243 SPLENIC INFARCTION 1 0.0006
244 LUNG DISORDER 28 0.0006
245 THROMBOPHLEBITIS 2 0.0006
246 TREATMENT FAILURE 47 0.0006
247 BONE EROSION 2 0.0006
248 THERAPEUTIC PRODUCT EFFECT DECREASED 25 0.0006
249 PYODERMA GANGRENOSUM 2 0.0006
250 FAECES SOFT 4 0.0005
251 IMMUNE-MEDIATED LUNG DISEASE 1 0.0005
252 EXOSTOSIS 5 0.0005
253 SOFT TISSUE INFECTION 1 0.0005
254 AURA 1 0.0005
255 PERIORBITAL SWELLING 3 0.0005
256 HYPOAESTHESIA 79 0.0005
257 URTICARIA 88 0.0005
258 CARCINOEMBRYONIC ANTIGEN INCREASED 1 0.0005
259 SENSATION OF HEAVINESS 2 0.0005
260 ALCOHOL INTERACTION 1 0.0005
261 PURULENCE 1 0.0005
262 IMMUNE-MEDIATED HEPATIC DISORDER 1 0.0005
263 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 36 0.0005
264 INFUSION RELATED REACTION 33 0.0005
265 HYPOPHYSITIS 1 0.0005
266 MUSCULOSKELETAL PAIN 26 0.0005
267 INJECTION SITE REACTION 34 0.0005
268 RENAL HAEMORRHAGE 1 0.0005
269 IMMUNE-MEDIATED HEPATITIS 1 0.0005
270 OSTEOLYSIS 1 0.0005
271 RENAL MASS 1 0.0005
272 CHEST INJURY 1 0.0005
273 INFUSION SITE EXTRAVASATION 3 0.0005
274 DYSPEPSIA 47 0.0005
275 DILATATION VENTRICULAR 1 0.0005
276 GASTROINTESTINAL DISORDER 42 0.0005
277 HYPERPHOSPHATAEMIA 1 0.0005
278 SPUTUM INCREASED 1 0.0005
279 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 3 0.0005
280 EXPOSED BONE IN JAW 1 0.0005
281 LIMB MASS 1 0.0005
282 RED BLOOD CELL SEDIMENTATION RATE INCREASED 5 0.0005
283 PERIPHERAL SWELLING 68 0.0004
284 SCIATICA 7 0.0004
285 READING DISORDER 1 0.0004
286 ORAL PRURITUS 1 0.0004
287 PANCREATITIS NECROTISING 1 0.0004
288 INFUSION SITE INFECTION 1 0.0004
289 OVARIAN HYPERSTIMULATION SYNDROME 1 0.0004
290 GENERAL PHYSICAL HEALTH DETERIORATION 49 0.0004
291 CARDIAC TAMPONADE 2 0.0004
292 IMPAIRED QUALITY OF LIFE 6 0.0004
293 PARAESTHESIA ORAL 6 0.0004
294 PARAESTHESIA 65 0.0004
295 PRODUCT QUALITY ISSUE 56 0.0004
296 ABDOMINAL DISTENSION 43 0.0004
297 AUTOIMMUNE DISORDER 4 0.0004
298 BREATH SOUNDS ABNORMAL 2 0.0004
299 CARTILAGE INJURY 1 0.0004
300 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
301 DERMATITIS EXFOLIATIVE 2 0.0004
302 METASTASES TO PERITONEUM 1 0.0004
303 DRUG TOLERANCE 2 0.0004
304 MEAN CELL VOLUME INCREASED 1 0.0004
305 AORTIC ARTERIOSCLEROSIS 1 0.0004
306 SWELLING 36 0.0004
307 END STAGE RENAL DISEASE 7 0.0004
308 MALABSORPTION 2 0.0004
309 APLASTIC ANAEMIA 2 0.0004
310 RADICULOPATHY 1 0.0004
311 MUSCULOSKELETAL STIFFNESS 33 0.0004
312 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 18 0.0004
313 ORAL FUNGAL INFECTION 1 0.0004
314 LOWER LIMB FRACTURE 7 0.0004
315 THYROID NEOPLASM 1 0.0004
316 DRUG SCREEN FALSE POSITIVE 1 0.0004
317 BREAST CANCER STAGE II 3 0.0004
318 INTESTINAL PERFORATION 4 0.0004
319 DRUG TOLERANCE DECREASED 1 0.0004
320 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0004
321 NECK MASS 1 0.0004
322 VITAMIN B12 DECREASED 1 0.0003
323 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
324 WEIGHT INCREASED 76 0.0003
325 PRODUCT USE ISSUE 62 0.0003
326 EMBOLISM VENOUS 1 0.0003
327 HIDRADENITIS 3 0.0003
328 PNEUMONIA 106 0.0003
329 MASTICATION DISORDER 1 0.0003
330 PAIN IN EXTREMITY 96 0.0003
331 MATERNAL EXPOSURE DURING PREGNANCY 29 0.0003
332 BLOOD BLISTER 1 0.0003
333 FAECAL CALPROTECTIN INCREASED 1 0.0003
334 ABSCESS 5 0.0003
335 PULMONARY FIBROSIS 6 0.0003
336 HAEMOGLOBIN ABNORMAL 2 0.0003
337 LOOSE TOOTH 1 0.0003
338 INCOHERENT 2 0.0003
339 EAR PAIN 6 0.0003
340 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0003
341 WALKING AID USER 2 0.0003
342 OTITIS MEDIA 1 0.0003
343 RESPIRATORY DISORDER 9 0.0003
344 ANXIETY DISORDER 1 0.0003
345 TONGUE ULCERATION 1 0.0003
346 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
347 NEUTROPHIL COUNT INCREASED 3 0.0003
348 MIGRAINE 27 0.0003
349 MACULOPATHY 1 0.0003
350 ABDOMINAL DISCOMFORT 47 0.0003
351 BLOOD PHOSPHORUS DECREASED 1 0.0003
352 FOOD INTOLERANCE 1 0.0003
353 SEBORRHOEA 1 0.0003
354 VENTRICULAR FIBRILLATION 3 0.0003
355 ABDOMINAL PAIN UPPER 55 0.0003
356 HEPATIC CIRRHOSIS 5 0.0003
357 PROTEIN TOTAL DECREASED 1 0.0003
358 BLOOD URINE PRESENT 5 0.0003
359 FEELING JITTERY 5 0.0003
360 PHARYNGEAL OEDEMA 4 0.0003
361 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
362 PANIC DISORDER 1 0.0003
363 OFF LABEL USE 226 0.0003
364 SWOLLEN TONGUE 8 0.0003
365 WOUND SECRETION 1 0.0003
366 GASTROINTESTINAL INFLAMMATION 2 0.0003
367 TORSADE DE POINTES 2 0.0003
368 SKIN ODOUR ABNORMAL 1 0.0003
369 FALL 84 0.0003
370 FURUNCLE 2 0.0003
371 OVERDOSE 54 0.0003
372 MEMORY IMPAIRMENT 34 0.0002
373 RECURRENT CANCER 1 0.0002
374 HYPERURICAEMIA 1 0.0002
375 CONGESTIVE CARDIOMYOPATHY 1 0.0002
376 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
377 ADVERSE EVENT 22 0.0002
378 CANDIDA INFECTION 4 0.0002
379 TONGUE DISCOMFORT 1 0.0002
380 CONFUSIONAL STATE 38 0.0002
381 AORTIC VALVE INCOMPETENCE 1 0.0002
382 FACIAL PARALYSIS 2 0.0002
383 DEPRESSION 53 0.0002
384 BLOOD MAGNESIUM DECREASED 2 0.0002
385 TOOTH INJURY 1 0.0002
386 TONGUE DISCOLOURATION 1 0.0002
387 DYSPHEMIA 1 0.0002
388 CATHETERISATION CARDIAC 1 0.0002
389 ARTHRALGIA 93 0.0002
390 HAEMOLYTIC ANAEMIA 2 0.0002
391 PAPILLOEDEMA 1 0.0002
392 SUSPECTED OFF LABEL USE 1 0.0002
393 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
394 PATHOGEN RESISTANCE 2 0.0002
395 CONTUSION 21 0.0002
396 ANAPHYLACTIC REACTION 12 0.0002
397 NEPHROGENIC ANAEMIA 1 0.0002
398 GASTRITIS EROSIVE 1 0.0002
399 MIDDLE INSOMNIA 4 0.0002
400 ALOPECIA 42 0.0002
401 DISCOMFORT 13 0.0002
402 SKIN REACTION 3 0.0002
403 PULSE ABSENT 1 0.0002
404 KIDNEY TRANSPLANT REJECTION 1 0.0002
405 APHAGIA 1 0.0002
406 HYPERTENSION 44 0.0002
407 HYPERTHYROIDISM 3 0.0002
408 RASH VESICULAR 1 0.0002
409 PRESCRIBED OVERDOSE 4 0.0002
410 INCORRECT DOSAGE ADMINISTERED 1 0.0002
411 VOMITING 95 0.0002
412 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
413 DELIRIUM 7 0.0002
414 ANEURYSM 1 0.0002
415 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
416 TRISMUS 1 0.0002
417 PERIORBITAL OEDEMA 1 0.0002
418 THERAPY PARTIAL RESPONDER 3 0.0002
419 TENDERNESS 2 0.0002
420 INSOMNIA 51 0.0002
421 JOINT STIFFNESS 5 0.0002
422 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
423 ANAL FISTULA 1 0.0002
424 ANAL ABSCESS 1 0.0002
425 STRESS FRACTURE 1 0.0002
426 MUSCLE SPASMS 34 0.0002
427 MUSCLE TIGHTNESS 3 0.0002
428 OEDEMA 10 0.0002
429 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
430 DEAFNESS UNILATERAL 1 0.0002
431 TOOTH FRACTURE 2 0.0002
432 HYPERKERATOSIS 1 0.0002
433 DRUG LEVEL INCREASED 3 0.0002
434 FOOT DEFORMITY 2 0.0002
435 NECROSIS 1 0.0002
436 PANCREATITIS ACUTE 4 0.0002
437 PERONEAL NERVE PALSY 1 0.0002
438 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
439 NEUROLOGICAL SYMPTOM 1 0.0002
440 CONDITION AGGRAVATED 53 0.0002
441 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
442 RALES 1 0.0002
443 ELECTROLYTE IMBALANCE 2 0.0002
444 HYPOVOLAEMIA 1 0.0002
445 OSTEOPOROSIS 7 0.0002
446 RASH 74 0.0002
447 PLEURISY 1 0.0002
448 CHOLECYSTITIS 2 0.0002
449 PROTHROMBIN TIME PROLONGED 1 0.0002
450 PLATELET COUNT ABNORMAL 1 0.0002
451 NASOPHARYNGITIS 30 0.0002
452 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
453 SCOLIOSIS 1 0.0002
454 EYE SWELLING 6 0.0002
455 SWELLING OF EYELID 1 0.0002
456 CHRONIC KIDNEY DISEASE 12 0.0002
457 PROTEINURIA 3 0.0002
458 PRODUCT USE IN UNAPPROVED INDICATION 39 0.0002
459 ADVERSE DRUG REACTION 14 0.0002
460 DRUG RESISTANCE 4 0.0002
461 ANAPHYLACTIC SHOCK 4 0.0002
462 HEPATITIS ACUTE 1 0.0002
463 ASTHENIA 57 0.0002
464 MALAISE 66 0.0002
465 POST-TRAUMATIC STRESS DISORDER 1 0.0001
466 CROHN'S DISEASE 1 0.0001
467 LARGE INTESTINE PERFORATION 1 0.0001
468 HYPERTRANSAMINASAEMIA 1 0.0001
469 EXTRASYSTOLES 1 0.0001
470 THERMAL BURN 1 0.0001
471 RETINAL HAEMORRHAGE 1 0.0001
472 PARALYSIS 2 0.0001
473 DIZZINESS 69 0.0001
474 PRODUCT DISPENSING ERROR 3 0.0001
475 ORAL DISORDER 1 0.0001
476 BLINDNESS TRANSIENT 1 0.0001
477 LIVER DISORDER 6 0.0001
478 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
479 STEVENS-JOHNSON SYNDROME 3 0.0001
480 TOOTH DISORDER 3 0.0001
481 RENAL INJURY 4 0.0001
482 SUNBURN 1 0.0001
483 HYDRONEPHROSIS 1 0.0001
484 THERAPY NON-RESPONDER 6 0.0001
485 GENERAL SYMPTOM 1 0.0001
486 PEMPHIGOID 1 0.0001
487 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
488 ACIDOSIS 1 0.0001
489 HIP ARTHROPLASTY 2 0.0001
490 BOWEL MOVEMENT IRREGULARITY 1 0.0001
491 DISSOCIATION 1 0.0001
492 RENAL FAILURE CHRONIC 1 0.0001
493 FOOD ALLERGY 1 0.0001
494 HAEMOLYSIS 1 0.0001
495 TENDONITIS 2 0.0001
496 APHTHOUS ULCER 1 0.0001
497 RENAL DISORDER 6 0.0001
498 HYPOALBUMINAEMIA 1 0.0001
499 PELVIC FRACTURE 1 0.0001
500 TRICUSPID VALVE INCOMPETENCE 1 0.0001
501 ULCER 2 0.0001
502 GINGIVAL PAIN 1 0.0001
503 METABOLIC ACIDOSIS 4 0.0001
504 BLOOD PRESSURE FLUCTUATION 3 0.0001
505 MYASTHENIA GRAVIS 1 0.0001
506 SWELLING FACE 8 0.0001
507 DECUBITUS ULCER 1 0.0001
508 CHOLELITHIASIS 4 0.0001
509 HAIR DISORDER 1 0.0001
510 SENSATION OF FOREIGN BODY 1 0.0001
511 INFUSION SITE ERYTHEMA 1 0.0001
512 FACE OEDEMA 2 0.0001
513 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
514 PSEUDOMONAS INFECTION 1 0.0001
515 UNRESPONSIVE TO STIMULI 3 0.0001
516 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
517 SPINAL OSTEOARTHRITIS 1 0.0001
518 TUMOUR LYSIS SYNDROME 1 0.0001
519 LYMPHOCYTE COUNT DECREASED 2 0.0001
520 DRUG ERUPTION 2 0.0001
521 EAR INFECTION 3 0.0001
522 WRONG DRUG ADMINISTERED 1 0.0001
523 FACIAL PAIN 1 0.0001
524 MYOSITIS 1 0.0001
525 NAUSEA 88 0.0001
526 THROAT TIGHTNESS 3 0.0001
527 GASTROENTERITIS VIRAL 2 0.0001
528 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
529 OROPHARYNGEAL DISCOMFORT 1 0.0001
530 DIARRHOEA 71 0.0001
531 BONE DISORDER 2 0.0001
532 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
533 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
534 DEFORMITY 1 0.0001
535 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
536 LEUKAEMIA 1 0.0001
537 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
538 FRACTURE 2 0.0001
539 GASTRIC ULCER 2 0.0001
540 EYE INFLAMMATION 1 0.0001
541 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
542 HOSPITALISATION 16 0.0001
543 ATELECTASIS 1 0.0001
544 HERNIA 2 0.0001
545 ERUCTATION 2 0.0001
546 PAIN 63 0.0001
547 INFLAMMATORY BOWEL DISEASE 1 0.0001
548 BODY TEMPERATURE DECREASED 1 0.0001
549 DISABILITY 2 0.0001
550 LIGAMENT SPRAIN 1 0.0001
551 PRESCRIBED UNDERDOSE 2 0.0001
552 FEELING HOT 6 0.0001
553 SINUSITIS 10 0.0001
554 EAR DISCOMFORT 1 0.0001
555 HYPERBILIRUBINAEMIA 1 0.0001
556 WEIGHT FLUCTUATION 1 0.0001
557 KNEE ARTHROPLASTY 2 0.0001
558 MOUTH ULCERATION 2 0.0001
559 INCONTINENCE 1 0.0001
560 JOINT DISLOCATION 1 0.0001
561 DYSPNOEA 53 0.0001
562 POOR QUALITY SLEEP 2 0.0001
563 DECREASED ACTIVITY 1 0.0001
564 BIPOLAR DISORDER 1 0.0001
565 PULMONARY THROMBOSIS 1 0.0001
566 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
567 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
568 GASTROINTESTINAL PAIN 1 0.0001
569 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
570 DENTAL CARIES 1 0.0001
571 MEDICATION ERROR 5 0.0001
572 PANCYTOPENIA 5 0.0001
573 MALNUTRITION 1 0.0001
574 SKIN INFECTION 1 0.0001
575 FISTULA 1 0.0001
576 EYE INFECTION 1 0.0001
577 MITRAL VALVE INCOMPETENCE 1 0.0001
578 CHEST DISCOMFORT 9 0.0001
579 SCAB 1 0.0001
580 FATIGUE 68 0.0001
581 SHOCK 2 0.0001
582 MUSCLE TWITCHING 2 0.0001
583 PERICARDIAL EFFUSION 2 0.0001
584 DECREASED APPETITE 20 0.0001
585 EYELID OEDEMA 1 0.0001
586 BONE PAIN 5 0.0001
587 CARDIAC ARREST 7 0.0001
588 ARRHYTHMIA 4 0.0001
589 BLOOD IRON DECREASED 1 0.0001
590 MYELOSUPPRESSION 3 0.0001
591 THYROID CANCER 1 0.0001
592 ADRENAL INSUFFICIENCY 1 0.0001
593 NOCTURIA 1 0.0001
594 NO THERAPEUTIC RESPONSE 1 0.0001
595 CYTOPENIA 1 0.0001
596 ABDOMINAL PAIN 19 0.0001
597 HEADACHE 51 0.0001
598 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
599 POISONING 1 0.0001
600 MUSCLE ATROPHY 1 0.0001
601 ACUTE KIDNEY INJURY 12 0.0001
602 INTRAOCULAR PRESSURE INCREASED 1 0.0001
603 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
604 ROTATOR CUFF SYNDROME 1 0.0001
605 INFUSION SITE PAIN 1 0.0001
606 RASH GENERALISED 2 0.0001
607 DIPLOPIA 2 0.0001
608 TOOTH INFECTION 1 0.0001
609 CHEST PAIN 14 0.0001
610 FEBRILE NEUTROPENIA 5 0.0001
611 INJECTION SITE PRURITUS 5 0.0001
612 FREQUENT BOWEL MOVEMENTS 2 0.0001
613 SINUS CONGESTION 1 0.0001
614 LIMB INJURY 2 0.0001
615 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
616 ORAL DISCOMFORT 1 0.0001
617 HUNGER 1 0.0001
618 CARPAL TUNNEL SYNDROME 1 0.0001
619 SEASONAL ALLERGY 1 0.0001
620 PAIN IN JAW 2 0.0001
621 DIALYSIS 1 0.0001
622 SINUS TACHYCARDIA 1 0.0001
623 PYREXIA 24 0.0001
624 HYPOKINESIA 1 0.0001
625 GASTROENTERITIS 1 0.0001
626 ASCITES 2 0.0001
627 BLADDER CANCER 4 0.0001
628 RENAL FAILURE 9 0.0001
629 URINARY INCONTINENCE 2 0.0001
630 COLON CANCER 1 0.0001
631 IMMUNODEFICIENCY 1 0.0001
632 HAEMORRHAGE INTRACRANIAL 1 0.0001
633 BONE LOSS 1 0.0001
634 HYPOAESTHESIA ORAL 1 0.0001
635 LACRIMATION INCREASED 2 0.0001
636 THERAPEUTIC RESPONSE DECREASED 4 0.0001
637 OSTEOPENIA 1 0.0001
638 OEDEMA PERIPHERAL 8 0.0001
639 DRUG DISPENSING ERROR 1 0.0001
640 TINNITUS 3 0.0001
641 DRUG INEFFECTIVE 86 0.0001
642 EJECTION FRACTION DECREASED 1 0.0001
643 NERVOUS SYSTEM DISORDER 2 0.0001
644 ARTHRITIS 5 0.0001
645 PNEUMOTHORAX 1 0.0001
646 GAIT DISTURBANCE 12 0.0001
647 SENSORY DISTURBANCE 1 0.0001
648 INFECTION 9 0.0001
649 ASTHMA 7 0.0001
650 BACK DISORDER 1 0.0001
651 AMNESIA 4 0.0001
652 VENTRICULAR TACHYCARDIA 1 0.0001
653 PHOTOSENSITIVITY REACTION 1 0.0001
654 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
655 DRY EYE 3 0.0001
656 LIP SWELLING 2 0.0001
657 FUNGAL INFECTION 2 0.0001
658 DEHYDRATION 8 0.0001
659 PRURITUS 23 0.0001
660 CELLULITIS 3 0.0001
661 EYE PRURITUS 2 0.0001
662 SCAR 1 0.0001
663 WEIGHT DECREASED 16 0.0001
664 NEUROTOXICITY 1 0.0001
665 HYPERKALAEMIA 2 0.0001
666 PANCREATITIS 3 0.0001
667 DRUG INTERACTION 9 0.0001
668 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
669 GALLBLADDER DISORDER 1 0.0001
670 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
671 LEUKOCYTOSIS 1 0.0001
672 OSTEOMYELITIS 1 0.0001
673 PANIC ATTACK 2 0.0001
674 RESPIRATORY FAILURE 4 0.0001
675 RESTLESSNESS 2 0.0001
676 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
677 AGRANULOCYTOSIS 1 0.0001
678 UNEVALUABLE EVENT 4 0.0001
679 HYPOCALCAEMIA 1 0.0001
680 COLITIS 2 0.0001
681 ANXIETY 15 0.0001
682 CHOLESTASIS 1 0.0001
683 SEIZURE 6 0.0001
684 HAEMORRHOIDS 1 0.0001
685 SKIN FISSURES 1 0.0001
686 NASAL CONGESTION 3 0.0001
687 HAEMATOCRIT DECREASED 1 0.0001
688 UPPER LIMB FRACTURE 1 0.0001
689 SYNCOPE 5 0.0000
690 PREGNANCY 1 0.0000
691 CYTOKINE RELEASE SYNDROME 1 0.0000
692 HYPOTENSION 10 0.0000
693 FEEDING DISORDER 1 0.0000
694 PLEURAL EFFUSION 3 0.0000
695 BODY TEMPERATURE INCREASED 1 0.0000
696 INFLUENZA LIKE ILLNESS 4 0.0000
697 TOOTH LOSS 1 0.0000
698 PULMONARY HYPERTENSION 1 0.0000
699 CARDIO-RESPIRATORY ARREST 2 0.0000
700 DERMATITIS 1 0.0000
701 RETCHING 1 0.0000
702 PRURITUS GENERALISED 1 0.0000
703 FAECES DISCOLOURED 1 0.0000
704 VAGINAL HAEMORRHAGE 2 0.0000
705 SEPTIC SHOCK 2 0.0000
706 PRODUCT PRESCRIBING ISSUE 1 0.0000
707 MELAENA 1 0.0000
708 TACHYCARDIA 4 0.0000
709 HEPATOTOXICITY 1 0.0000
710 COLITIS ULCERATIVE 2 0.0000
711 SOMNOLENCE 9 0.0000
712 ORAL PAIN 1 0.0000
713 RASH PAPULAR 1 0.0000
714 SNEEZING 1 0.0000
715 THROAT IRRITATION 2 0.0000
716 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
717 HEART RATE IRREGULAR 1 0.0000
718 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
719 COMA 2 0.0000
720 THERAPY INTERRUPTED 3 0.0000
721 RASH ERYTHEMATOUS 2 0.0000
722 DIABETIC KETOACIDOSIS 1 0.0000
723 LOCALISED INFECTION 1 0.0000
724 PRESYNCOPE 1 0.0000
725 NEURALGIA 1 0.0000
726 BRONCHITIS 3 0.0000
727 ABASIA 1 0.0000
728 OSTEONECROSIS OF JAW 1 0.0000
729 INJECTION SITE ERYTHEMA 5 0.0000
730 PNEUMONIA ASPIRATION 1 0.0000
731 COVID-19 7 0.0000
732 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
733 PRODUCT COMPLAINT 1 0.0000
734 DIABETES MELLITUS 3 0.0000
735 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
736 ILLNESS 4 0.0000
737 SKIN ULCER 1 0.0000
738 HAEMATOMA 1 0.0000
739 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
740 RESPIRATORY TRACT INFECTION 1 0.0000
741 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
742 DEAFNESS 1 0.0000
743 ECZEMA 2 0.0000
744 ANHEDONIA 1 0.0000
745 GASTRITIS 1 0.0000
746 PROSTATE CANCER 3 0.0000
747 RASH PRURITIC 2 0.0000
748 PNEUMONITIS 1 0.0000
749 ANAEMIA 7 0.0000
750 TREATMENT NONCOMPLIANCE 2 0.0000
751 SKIN LESION 1 0.0000
752 VISION BLURRED 5 0.0000
753 PROCEDURAL PAIN 1 0.0000
754 INFLUENZA 4 0.0000
755 EYE PAIN 2 0.0000
756 MYALGIA 6 0.0000
757 FLATULENCE 2 0.0000
758 ANGINA PECTORIS 1 0.0000
759 LIVER FUNCTION TEST ABNORMAL 1 0.0000
760 DYSPHONIA 2 0.0000
761 SURGERY 2 0.0000
762 LABORATORY TEST ABNORMAL 1 0.0000
763 PSYCHOTIC DISORDER 1 0.0000
764 CATARACT 2 0.0000
765 VERTIGO 2 0.0000
766 SUICIDAL IDEATION 3 0.0000
767 BLOOD PRESSURE INCREASED 5 0.0000
768 EMOTIONAL DISORDER 1 0.0000
769 LIMB DISCOMFORT 1 0.0000
770 VISUAL IMPAIRMENT 4 0.0000
771 HEAD INJURY 1 0.0000
772 NEUROPATHY PERIPHERAL 3 0.0000
773 HYPOTHYROIDISM 1 0.0000
774 MOVEMENT DISORDER 1 0.0000
775 HIP FRACTURE 1 0.0000
776 HYPERHIDROSIS 4 0.0000
777 RHINORRHOEA 2 0.0000
778 BLOOD CREATININE INCREASED 2 0.0000
779 OSTEONECROSIS 1 0.0000
780 HEART RATE INCREASED 3 0.0000
781 BACK PAIN 7 0.0000
782 VIRAL INFECTION 1 0.0000
783 SKIN DISORDER 1 0.0000
784 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
785 HAEMATURIA 1 0.0000
786 GASTRIC DISORDER 1 0.0000
787 NEOPLASM PROGRESSION 1 0.0000
788 HEART RATE DECREASED 1 0.0000
789 HYPOXIA 1 0.0000
790 LYMPHADENOPATHY 1 0.0000
791 PLATELET COUNT DECREASED 3 0.0000
792 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
793 CONSTIPATION 6 0.0000
794 HEPATIC FUNCTION ABNORMAL 1 0.0000
795 EPISTAXIS 2 0.0000
796 DYSPNOEA EXERTIONAL 1 0.0000
797 CHILLS 3 0.0000
798 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
799 FEELING ABNORMAL 6 0.0000
800 COUGH 7 0.0000
801 CARDIAC FAILURE CONGESTIVE 2 0.0000
802 THROMBOSIS 2 0.0000
803 DYSKINESIA 1 0.0000
804 BLINDNESS 1 0.0000
805 LUNG NEOPLASM MALIGNANT 1 0.0000
806 ERYTHEMA 5 0.0000
807 TREMOR 4 0.0000
808 RHABDOMYOLYSIS 1 0.0000
809 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
810 ROAD TRAFFIC ACCIDENT 1 0.0000
811 PRODUCT DOSE OMISSION ISSUE 7 0.0000
812 LOSS OF CONSCIOUSNESS 3 0.0000
813 RECTAL HAEMORRHAGE 1 0.0000
814 HYPOACUSIS 1 0.0000
815 BALANCE DISORDER 2 0.0000
816 PSORIASIS 3 0.0000
817 ANGIOEDEMA 1 0.0000
818 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
819 NEPHROLITHIASIS 1 0.0000
820 SKIN DISCOLOURATION 1 0.0000
821 HYPOKALAEMIA 1 0.0000
822 OROPHARYNGEAL PAIN 2 0.0000
823 COGNITIVE DISORDER 1 0.0000
824 OCULAR HYPERAEMIA 1 0.0000
825 DYSPHAGIA 2 0.0000
826 DISEASE RECURRENCE 1 0.0000
827 PRODUCTIVE COUGH 1 0.0000
828 DEATH 18 0.0000
829 INTERSTITIAL LUNG DISEASE 1 0.0000
830 HYPOGLYCAEMIA 1 0.0000
831 LEUKOPENIA 1 0.0000
832 FLUSHING 2 0.0000
833 FLUID RETENTION 1 0.0000
834 NERVOUSNESS 1 0.0000
835 SPEECH DISORDER 1 0.0000
836 BRADYCARDIA 1 0.0000
837 DISTURBANCE IN ATTENTION 1 0.0000
838 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
839 OXYGEN SATURATION DECREASED 1 0.0000
840 URINARY TRACT INFECTION 3 0.0000
841 CONVULSION 1 0.0000
842 HERPES ZOSTER 1 0.0000
843 EYE IRRITATION 1 0.0000
844 PALPITATIONS 2 0.0000
845 IRRITABILITY 1 0.0000
846 NO ADVERSE EVENT 3 0.0000
847 EMOTIONAL DISTRESS 2 0.0000
848 NEOPLASM MALIGNANT 1 0.0000
849 DEVICE MALFUNCTION 1 0.0000
850 DYSGEUSIA 1 0.0000
851 HOT FLUSH 1 0.0000
852 INJECTION SITE BRUISING 1 0.0000
853 DRUG DOSE OMISSION 2 0.0000
854 COMPLETED SUICIDE 1 0.0000
855 RENAL IMPAIRMENT 1 0.0000
856 MYOCARDIAL INFARCTION 2 0.0000
857 PRODUCT STORAGE ERROR 1 0.0000
858 BREAST CANCER 1 0.0000
859 CARDIAC DISORDER 1 0.0000
860 ATRIAL FIBRILLATION 1 0.0000
861 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
862 HAEMOGLOBIN DECREASED 1 0.0000
863 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
864 HAEMORRHAGE 1 0.0000
865 SEPSIS 1 0.0000
866 THROMBOCYTOPENIA 1 0.0000
867 INCORRECT DOSE ADMINISTERED 2 0.0000
868 DISEASE PROGRESSION 1 0.0000
869 NEUTROPENIA 1 0.0000
870 TOXICITY TO VARIOUS AGENTS 1 0.0000
871 BLOOD GLUCOSE INCREASED 1 0.0000
872 INJECTION SITE PAIN 1 0.0000